Else Nutrition

Company Overview

Snapshot

Founded in February 2012 by Hamutal (Cohen) Yitzhak and Uriel Kesler, Else Nutrition operates with 11–50 employees. The company has raised $62.18 million across 11 funding rounds and went public on the TSX in October 2021. In June 2024, Else Nutrition secured $2 million in an offering of units from a healthcare-focused institutional investor.

Business overview

Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children, and adults. The company's core product is a non-soy formula that serves as an alternative to dairy-based formulas, utilizing ingredients such as almonds, buckwheat, and tapioca. Else Nutrition targets markets seeking clean-label, plant-based nutritional alternatives, operating within the Agriculture & Food Technologies sector, specifically focusing on Food Tech and Novel Food & Ingredients.

Strategic signal

In June 2026, Else Nutrition initiated a manufacturing drive, signaling a strategic focus on scaling production to meet growing demand. This operational expansion suggests the company is preparing for increased market penetration and aims to strengthen its supply chain efficiency, which is crucial for a consumer goods company in the nutrition sector.

Company Intelligence Q&A

What was a significant financial event for Else Nutrition in June 2024?

In June 2024, Else Nutrition announced a US$2 million offering of units, priced at-the-market, to a healthcare-focused institutional investor. The proceeds are intended for research and development, sales and marketing, inventory acquisition, and general corporate purposes.

What was the outcome of Else Nutrition's Q1 2026 earnings report?

In May 2026, Else Nutrition reported its first quarter 2026 results, highlighting significant improvement in gross margin and a reduced net loss.

What strategic move did Else Nutrition announce for the Canadian market in January 2026?

In January 2026, Else Nutrition announced plans to relaunch its Canadian business, transitioning to a direct distribution model to improve margins and commercial control, with an expected initial-year revenue of CAD$500,000.

What key management change occurred at Else Nutrition in January 2026?

In January 2026, Else Nutrition appointed Natie Zilberberg as the new Chief Financial Officer and Corporate Secretary, a strategic move to support the company's growth and expansion plans.

What regulatory breakthrough did Else Nutrition announce in November 2025?

In November 2025, Else Nutrition announced a major breakthrough with the U.S. Government's passage of the Fiscal Year 2026 budget, which included directives to expedite FDA pathways for plant-based, non-soy, non-dairy infant formulas, streamlining regulatory processes for its products.